HS
MRNA icon

Horan Securities’s Moderna MRNA Stock Holding History

Horan Securities’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-35
Closed -$4.31K – 443
2023
Q2 		$4.31K Hold
35
– – ﹤0.01% 490
2023
Q1 		$5.44K Sell
35
-86
-71% -$14.2K ﹤0.01% 460
2022
Q4 		$21.8K Sell
121
-3
-2% -$491 0.01% 288
2022
Q3 		$15K Hold
124
– – 0.01% 307
2022
Q2 		$20K Sell
124
-203
-62% -$29K 0.01% 258
2022
Q1 		$56K Sell
327
-139
-30% -$23.4K 0.03% 167
2021
Q4 		$118K Buy
+466
New +$136K 0.07% 121
2021
Q2 		$179K Sell
761
-435
-36% -$77.7K 0.13% 76
2021
Q1 		$157K Buy
1,196
+16
+1% +$2.32K 0.13% 60
2020
Q4 		$123K Buy
+1,180
New +$119K 0.1% 69

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return